Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Calcium-channel blockers and risk of cancer.

Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR.

Lancet. 1997 Feb 22;349(9051):525-8.

PMID:
9048789
2.
3.

Do calcium channel blockers increase the risk of cancer?

Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ.

Am J Hypertens. 1996 Jul;9(7):695-9.

PMID:
8806983
5.

Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.

Schaer BA, Schneider C, Jick SS, Conen D, Osswald S, Meier CR.

Ann Intern Med. 2010 Jan 19;152(2):78-84. doi: 10.7326/0003-4819-152-2-201001190-00005.

PMID:
20083826
6.

Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.

Michels KB, Rosner BA, Walker AM, Stampfer MJ, Manson JE, Colditz GA, Hennekens CH, Willett WC.

Cancer. 1998 Nov 1;83(9):2003-7.

PMID:
9806660
7.
8.

Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.

Meier CR, Derby LE, Jick SS, Jick H.

Arch Intern Med. 2000 Feb 14;160(3):349-53.

PMID:
10668837
9.

Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding.

Kaplan RC, Heckbert SR, Koepsell TD, Rosendaal FR, Psaty BM.

Arch Intern Med. 2000 Jun 26;160(12):1849-55.

PMID:
10871980
11.

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

Friis S, Sørensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL, Blot WJ, Olsen JH.

Cancer. 2001 Nov 1;92(9):2462-70.

PMID:
11745304
12.

Antihypertensive medications and risk of community-acquired pneumonia.

Mukamal KJ, Ghimire S, Pandey R, O'Meara ES, Gautam S.

J Hypertens. 2010 Feb;28(2):401-5. doi: 10.1097/HJH.0b013e3283330948.

PMID:
20051911
13.

Association between cardiovascular outcomes and antihypertensive drug treatment in older women.

Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.

JAMA. 2004 Dec 15;292(23):2849-59. Erratum in: JAMA. 2005 Apr 6;293(13):1594.

PMID:
15598916
14.

Long-term use of angiotensin receptor blockers and the risk of cancer.

Azoulay L, Assimes TL, Yin H, Bartels DB, Schiffrin EL, Suissa S.

PLoS One. 2012;7(12):e50893. doi: 10.1371/journal.pone.0050893. Epub 2012 Dec 12.

15.

The calcium channel blocker controversy in perspective.

Zanchetti A.

Cardiology. 1997;88 Suppl 1:66-70; discussion 71-2. Review.

PMID:
9118170
16.
17.

ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.

Morgan TO, Anderson AI, MacInnis RJ.

Am J Hypertens. 2001 Mar;14(3):241-7.

PMID:
11281235
18.

Antihypertensive drugs and the risk of incident rosacea.

Spoendlin J, Voegel JJ, Jick SS, Meier CR.

Br J Dermatol. 2014 Jul;171(1):130-6. doi: 10.1111/bjd.12838. Epub 2014 Jul 6.

PMID:
24428524
19.

Antihypertensive drugs and the risk of idiopathic aplastic anaemia.

Myers MW, Vasilakis C, Kaufman MR, Jick H.

Br J Clin Pharmacol. 2000 Jun;49(6):604-8.

20.

[Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].

Baumgart P, Reismann J, Pohlmeyer H, Düsing R.

Dtsch Med Wochenschr. 2001 May 11;126(19):547-50. German.

PMID:
11402910
Items per page

Supplemental Content

Write to the Help Desk